Potential impact of apixaban on hospital resource use in patients with venous thromboembolism

Back

ESC Premium Access

Potential impact of apixaban on hospital resource use in patients with venous thromboembolism

Session: Antithrombotics in daily clinical practice

Topic: Thrombosis and coagulation

Speaker: Doctor X. Li (Princeton, US)

Event: ESC Congress 2016

Congress Presentation

Add to my library

About the speaker

Doctor Xiaoyan Li

Princeton (United States of America)

0 follower

9 more presentations in this session

Equal safety of rivaroxaban and vitamin K antagonists with regard to the risk of intracranial- and gastrointestinal bleeding in patients with venous thromboembolism - A Danish nationwide study

Speaker: Ms C. Clausen (Hellerup, DK)

Access

Abstract

Risk of venous thromboembolism recurrences in patients who continued versus discontinued rivaroxaban therapy after an initial six-month therapy

Speaker: Doctor C. Crivera (Raritan, NJ, US)

Very low-dose recombinant factor VIIa for optimized treatment of cardiovascular patients at high risk of hemorrhage

Speaker: Doctor A. Assmann (Duesseldorf, DE)

Efficacy and bleeding risk of newer anticoagulants compared to conventional treatment in patients with chronic kidney disease- a meta analysis of randomized controlled trials

Speaker: Assistant Professor K. Prudhvi (Tucson, US)

Management of acute venous thromboembolism in Europe - follow-up data at 1 month from the PREFER in VTE registry

Speaker: Doctor A. Cohen (London, GB)

Access the full session

Antithrombotics in daily clinical practice

Speakers: Doctor X. Li, Ms C. Clausen, Doctor C. Crivera, Doctor A. Assmann, Assistant Professor K. Prudhvi...

Access

About the event

ESC Congress 2016

27 August - 31 August 2016

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources